论文部分内容阅读
新的抗病毒剂研制进展缓慢,因它涉及到三方面问题:①设计较好的诊断方法以便弄清病毒性疾病;②确定和弄清病毒性疾病的自然经过以提出疗效标准;③详细阐明抗病毒剂的代谢作用。由于病毒在宿主细胞内复制,因此需要药物在细胞内发挥作用。
The development of a new anti-viral agent has been slow because it involves three aspects: ① designing better diagnostic methods to identify viral diseases; ② identifying and clarifying the natural course of viral diseases to propose efficacy standards; ③ clarifying Anti-viral agent metabolism. Because the virus replicates in the host cell, it is necessary for the drug to act in the cell.